Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Antibodies fused to innate immune molecules reduce initiation of Cryptosporidium parvum infection in mice.

Imboden M, Riggs MW, Schaefer DA, Homan EJ, Bremel RD.

Antimicrob Agents Chemother. 2010 Apr;54(4):1385-92. doi: 10.1128/AAC.00754-09. Epub 2010 Jan 19.

4.

Protective monoclonal antibody defines a circumsporozoite-like glycoprotein exoantigen of Cryptosporidium parvum sporozoites and merozoites.

Riggs MW, Stone AL, Yount PA, Langer RC, Arrowood MJ, Bentley DL.

J Immunol. 1997 Feb 15;158(4):1787-95.

PMID:
9029117
5.

Elongation factor-1α is a novel protein associated with host cell invasion and a potential protective antigen of Cryptosporidium parvum.

Matsubayashi M, Teramoto-Kimata I, Uni S, Lillehoj HS, Matsuda H, Furuya M, Tani H, Sasai K.

J Biol Chem. 2013 Nov 22;288(47):34111-20. doi: 10.1074/jbc.M113.515544. Epub 2013 Sep 30.

6.

Expression of the recombinant fusion protein CP15-23 of Cryptosporidium parvum and its protective test.

Hong-Xuan H, Lei C, Cheng-Min W, Kai Z, Yi T, Xi-Ming Q, Ming-Xing D.

J Nanosci Nanotechnol. 2005 Aug;5(8):1292-6.

PMID:
16193995
7.
8.

Divalent Cp15-23 vaccine enhances immune responses and protection against Cryptosporidium parvum infection.

Liu K, Zai D, Zhang D, Wei Q, Han G, Gao H, Huang B.

Parasite Immunol. 2010 May;32(5):335-44. doi: 10.1111/j.1365-3024.2009.01191.x.

12.

In vitro inhibition of Cryptosporidium parvum infection by human monoclonal antibodies.

Elliot BC, Wisnewski AV, Johnson J, Fenwick-Smith D, Wiest P, Hamer D, Kresina T, Flanigan TP.

Infect Immun. 1997 Sep;65(9):3933-5.

14.

Cryptosporidium parvum and mucosal immunity in neonatal cattle.

Wyatt CR.

Anim Health Res Rev. 2000 Jun;1(1):25-34. Review.

PMID:
11706841
15.

Application of recombinant Cryptosporidium parvum P23 for isolation and prevention.

Omidian Z, Ebrahimzadeh E, Shahbazi P, Asghari Z, Shayan P.

Parasitol Res. 2014 Jan;113(1):229-37. doi: 10.1007/s00436-013-3648-0. Epub 2013 Oct 24.

PMID:
24154594
16.

Selection and identification of a new adhesion protein of Cryptosporidium parvum from a cDNA library by ribosome display.

Xiao D, Yin C, Zhang Q, Li JH, Gong PT, Li SH, Zhang GC, Gao YJ, Zhang XC.

Exp Parasitol. 2011 Oct;129(2):183-9. doi: 10.1016/j.exppara.2011.06.004. Epub 2011 Jun 29.

PMID:
21740903
17.

Cryptosporidiosis: host immune responses and the prospects for effective immunotherapies.

McDonald V.

Expert Rev Anti Infect Ther. 2011 Nov;9(11):1077-86. doi: 10.1586/eri.11.123. Review.

PMID:
22029525
18.

Innate and cell-mediated immune responses to Cryptosporidium parvum.

Theodos CM.

Adv Parasitol. 1998;40:87-119. Review.

PMID:
9554071
19.

Evaluation of DNA encoding acidic ribosomal protein P2 of Cryptosporidium parvum as a potential vaccine candidate for cryptosporidiosis.

Benitez A, Priest JW, Ehigiator HN, McNair N, Mead JR.

Vaccine. 2011 Nov 15;29(49):9239-45. doi: 10.1016/j.vaccine.2011.09.094. Epub 2011 Oct 1.

20.

Protective monoclonal antibodies define a distinct, conserved epitope on an apical complex exoantigen of Cryptosporidium parvum sporozoites.

Riggs MW, Yount PA, Stone AL, Langer RC.

J Eukaryot Microbiol. 1996 Sep-Oct;43(5):74S-75S. No abstract available.

PMID:
8822870

Supplemental Content

Support Center